These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4383144)

  • 1. Mechanism of the protective effect of reserpine on aggregated mice treated with (+)-amphetamine.
    Menon MK; Dandiya PC
    J Pharm Pharmacol; 1967 Sep; 19(9):596-602. PubMed ID: 4383144
    [No Abstract]   [Full Text] [Related]  

  • 2. On the relationship between drug-induced changes in brain amines and body temperature.
    Ingenito AJ; Bonnycastle DD
    Can J Physiol Pharmacol; 1967 Jul; 45(4):723-32. PubMed ID: 5298528
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug interactions with brain biogenic amines and the effects of amphetamine isomers on locomotor activity.
    Zabik JE; Levine RM; Maickel RP
    Pharmacol Biochem Behav; 1978 Apr; 8(4):429-35. PubMed ID: 149988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dopalanine on behaviour in mice depleted of norepinephrine or serotonin.
    Chruściel TL; Herman ZS
    Psychopharmacologia; 1969; 14(2):124-34. PubMed ID: 5350621
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of pretreatment with reserpine, -methyl-p-tyrosine, or prostaglandin E 1 on adrenergic salivation.
    Koppanyi T; Maling HM
    Proc Soc Exp Biol Med; 1972 Jul; 140(3):787-93. PubMed ID: 5039376
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
    Ahlenius S
    Neuropharmacology; 1974 Aug; 13(8):729-39. PubMed ID: 4444759
    [No Abstract]   [Full Text] [Related]  

  • 7. Disulfiram and the drug-induced effects on motility.
    Maj J; Przegaliński E; Wielosz M
    J Pharm Pharmacol; 1968 Mar; 20(3):247-8. PubMed ID: 4385060
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of the aggressiveness-stereotypy complex induced in mice by amphetamine or D,L-dopa. II.
    Roliński Z
    Pol J Pharmacol Pharm; 1974; 26(3):369-78. PubMed ID: 4277363
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of reserpine, alpha-methyltyrosine, and L-3,4-dihydroxyphenylalanine on brain tyrosine transaminase.
    Gibb JW; Webb JG
    Proc Natl Acad Sci U S A; 1969 Jun; 63(2):364-9. PubMed ID: 4389816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refillment of the catecholamine stores with 3,4-dihydroxyphenylalanine after depletion induced by inhibition of tyrosine-hydroxylase.
    Corrodi H; Fuxe K; Hökfelt T
    Life Sci; 1966 Apr; 5(7):605-11. PubMed ID: 5960198
    [No Abstract]   [Full Text] [Related]  

  • 11. Catecholamines, drugs, and behavior: mutual interactions.
    Seiden LS; Campbell AB
    Adv Biochem Psychopharmacol; 1974; 12(0):325-38. PubMed ID: 4418348
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of CNS catecholamine-depleting drugs on dextroamphetamine-induced elevation of halothane MAC.
    Johnston RR; Way WL; Miller RD
    Anesthesiology; 1974 Jul; 41(1):57-61. PubMed ID: 4275974
    [No Abstract]   [Full Text] [Related]  

  • 13. Specific inhibition by -methyltyrosine of amphetamine-induced amine release from brain.
    Enna SJ; Dorris RL; Shore PA
    J Pharmacol Exp Ther; 1973 Mar; 184(3):576-82. PubMed ID: 4687221
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of L-DOPA on brain catecholamines and motility in rats.
    Maj J; Grabowska M; Mogilnicka E
    Psychopharmacologia; 1971; 22(2):162-71. PubMed ID: 5124189
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
    Corrodi H; Fuxe K
    Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
    [No Abstract]   [Full Text] [Related]  

  • 16. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
    Segal DS; McAllister C; Geyer MA
    Pharmacol Biochem Behav; 1974; 2(1):79-86. PubMed ID: 4857225
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence that the CCENTRAL ACTION OF (+)-amphetamine is mediated via catecholamines.
    Hanson LC
    Psychopharmacologia; 1967; 10(4):289-97. PubMed ID: 5592154
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetics of audiogenic seizures. 3. Time response relationships between drug administration and seizure susceptibility.
    Schlesinger K; Boggan WO; Freedman DX
    Life Sci I; 1970 Jul; 9(13):721-9. PubMed ID: 4394568
    [No Abstract]   [Full Text] [Related]  

  • 19. Importance of catecholamines for the interaction between reserpine and desipramine on body temperature in rats.
    Jori A; Bernardi D
    Pharmacology; 1970; 4(4):235-41. PubMed ID: 5489997
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines.
    Fulton SC; Healy MD
    Fed Proc; 1976 Dec; 35(14):2558-62. PubMed ID: 11134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.